HOME >> BIOLOGY >> NEWS
Taxanes may enhance immunity in breast cancer patients

COLUMBUS, Ohio Breast cancer patients treated with taxanes as part of their chemotherapy regimen have stronger immune systems one year after completing therapy than do women undergoing similar treatments without taxanes a finding that turns conventional medical wisdom on its head.

Researchers in the Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute studied 227 women enrolled in a multi-year study examining the relationship between stress and immunity in women with breast cancer. They divided the group into women who received taxanes as part of their treatment (55) and those who did not (172).

Researchers took blood from the patients and measured levels of key markers of the patients' immune status at two points in time, immediately after the women joined the study and one year following completion of treatment. Their analysis of the blood looked at the activity of the patient's T cells (white blood cells that can fight infections and cancer cells) and natural killer (NK) cells (another type of white blood cell that can kill cancer cells and cells infected with viruses).

They found that T cell growth was 37 percent higher and that the cancer killing activity of the NK cells was 39 percent higher in women receiving taxanes versus those who did not.

Scientists controlled for multiple variables that might contribute to the strength of the patients' immune function, including age, menopausal status, hormone receptor status, treatment, hormonal therapy at 12 months and cell counts, among others.

"This was totally unexpected," says Dr. William Carson, a surgeon and associate director of clinical research for the OSUCCC-James. "Most oncologists believe taxanes just like the rest of the chemotherapeutic agents we use suppress the immune system, not enhance it."

The study is published in the May 15 issue of Clinical Cancer Research.

Carson sa
'"/>

Contact: Michelle Gailiun
gailiun.1@osu.edu
614-293-3737
Ohio State University
6-May-2004


Page: 1 2

Related biology news :

1. Potential for enhanced sequestration of carbon in soils supports evaluations
2. Probing the surface of white blood cells to enhance immune system medicine
3. Protective gene may enhance vaccine responses
4. Plant gene discovery could enhance plant growth, reduce fertilizer needs and phosphate pollution
5. Technology could enhance accuracy of breast biopsy
6. Manipulating biotope space can enhance beneficial biodiversity effects
7. UC Riverside researchers develop low-carb corn with enhanced protein and oil
8. Athletics, genetic enhancement and ethics
9. Carnegie Mellon enhances Quantum Dot Corp. technology for long-term, live-animal imaging
10. Practice-based interventions enhance quality of care
11. Scientists discover potential approaches to enhance existing cancer therapies

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/16/2016)... , June 16, 2016 ... is expected to reach USD 1.83 billion by ... View Research, Inc. Technological proliferation and increasing demand ... are expected to drive the market growth. ... The development of advanced multimodal techniques ...
(Date:6/9/2016)... leader in attendance control systems is proud to announce the introduction of fingerprint attendance ... the right employees are actually signing in, and to even control the opening of ... ... ... Photo - ...
(Date:6/7/2016)... -- Syngrafii Inc. and San Antonio Credit Union (SACU) ... Syngrafii,s patented LongPen™ eSignature "Wet" solution into SACU,s ... in greater convenience for SACU members and operational ... document workflow and compliance requirements. Logo ... Highlights: ...
Breaking Biology News(10 mins):
(Date:12/6/2016)... ... December 06, 2016 , ... The ... asking the Federal Drug Administration (FDA) to consider OA as a serious disease. ... concerned about the growing population of OA patients, many of whom may experience ...
(Date:12/6/2016)... , ... December 06, 2016 ... ... Great Point Partners ("GPP") portfolio company, today announced it has acquired the ... a subsidiary of Chiltern International and focuses on clinical trial drug packaging, ...
(Date:12/6/2016)... 6, 2016  SRI International has been awarded ... the National Institutes of Health,s National Institute of ... AIDS (NIAID-DAIDS) to support the manufacturing and characterization ... agents. Under the seven-year contract, SRI will provide ... for candidate HIV-prevention products that emerge from investigator-initiated ...
(Date:12/5/2016)... Axovant Sciences Ltd. (NYSE: AXON ... treatment of dementia, today announced that data on the ... disease will be presented at the 2016 Clinical Trials ... 2016 in San Diego . Intepirdine ... and complex measures of activities of daily living (ADLs) ...
Breaking Biology Technology:
Cached News: